Diagnostic Biomarkers for Alzheimer’s Disease Using Non-Invasive Specimens
Studies in the field of Alzheimer’s disease (AD) have shown the emergence of biomarkers in biologic fluids that hold great promise for the diagnosis of the disease. A diagnosis of AD at a presymptomatic or early stage may be the key for a successful treatment, with clinical trials currently investig...
Main Authors: | Maria Paraskevaidi, David Allsop, Salman Karim, Francis L. Martin, StJohn Crean |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/6/1673 |
Similar Items
-
Quantification of Two Fluorophores’ Concentration Ratio in a Mice Model in Preparation for a Proposed Method for Early Detection of Alzheimer’s Disease
by: Osnat Harbater, et al.
Published: (2018-05-01) -
Oral Biofluid Biomarker Research: Current Status and Emerging Frontiers
by: Austin Wang, et al.
Published: (2016-12-01) -
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
by: Henrik Zetterberg, et al.
Published: (2021-02-01) -
Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease
by: Mohammad Arastoo, et al.
Published: (2020-11-01) -
Biomarkers for Alzheimer’s Disease Early Diagnosis
by: Eva Ausó, et al.
Published: (2020-09-01)